メラトニン市場：原料別・種類別・エンドユーザー別・地域別（2026～2032年）

メラトニン市場の評価（2026～2032年）

メラトニン産業は、睡眠障害とメラトニンサプリメントの利点に対する意識の高まりによって急速に拡大しています。ストレスレベルの上昇、高齢者人口の増加、自然健康療法へのシフトなどが市場成長に寄与しています。北米の市場シェアは大きいです。このため、市場規模は2024年に18億6,000万米ドルを突破し、2032年には約49億3,000万米ドルに達する見込みです。

メラトニン製剤の技術的進歩やオンライン小売セクターの拡大が市場拡大の原動力となっています。オーダーメイドの健康とウェルネス・ソリューションへの取り組みも需要を押し上げています。Natrol社、Life Extension社、Swanson Health Products社は、製品の革新と戦略的提携によって市場での地位を強化している主要な市場参入企業です。メラトニンに対する需要の高まりは、2026年から2032年にかけて14.30%のCAGRで市場の成長を可能にしています。

メラトニン市場の定義/概要

メラトニンは脳の松果体から分泌される天然ホルモンで、睡眠覚醒サイクルを調節します。リラックスを促し、睡眠の質を高めることで、睡眠障害、時差ぼけ、交代勤務関連の懸念の治療を支援する栄養補助食品として一般的に使用されています。

メラトニンは一般に、睡眠覚醒サイクルの調整、不眠症の治療、時差ぼけの予防に使用されます。また、小児の睡眠異常、手術前の不安、交代勤務者の睡眠強化の治療にも用いられます。メラトニンには抗酸化作用もあり、目の健康や季節性情動障害（SAD）を助ける可能性があります。

メラトニンの将来的な用途としては、睡眠調節に加えて、気分障害、時差ぼけ、免疫学的サポートなどが考えられます。抗酸化作用や抗炎症作用に関する研究が進めば、より大きな医薬品としての応用が期待され、ホリスティックな健康・ウェルネス戦略における重要性が高まると思われます。

睡眠障害に対する意識の高まりはメラトニン市場の成長を促進するか？

睡眠障害に対する意識の高まりは、米国人の間でこれらの症状がかなり蔓延していることから、メラトニン市場の成長を大きく後押しする構えです。

米国疾病予防管理センター（CDC）によると、約7,000万人の米国人が慢性的な睡眠の問題に苦しんでおり、これには不眠症、睡眠時無呼吸症候群、不十分な睡眠時間などの様々な病気が含まれます。米国睡眠協会によると、米国では5,000万～7,000万人の成人が1つ以上の睡眠問題に悩まされているといいます。

このような意識の高まりは、メラトニン・サプリメントに対する消費者の需要の増加につながり、睡眠パターンの調整と全体的な睡眠の質の向上におけるメラトニンの役割に関する知識の向上につながっています。2007年から2012年にかけて、米国国立保健統計センターは、米国におけるメラトニンサプリメントの使用が大幅に増加し、人口の0.6%から1.3%へと2倍以上に増えたと報告しています。この開発は、自然健康療法や個々人に合わせたウェルネス・ソリューションへの幅広いシフトを反映しており、メラトニン・サプリメントは睡眠障害の治療に有効であると認識され、ますます人気が高まっています。メラトニン製品の処方や流通チャネルの開発とともに認知度が高まるにつれ、市場は顧客の欲求や嗜好の拡大に対応してさらに拡大すると思われます。

安全性問題と副作用の増加はメラトニン市場の妨げになるか？

メラトニンの使用に関連する安全性への懸念や望ましくない結果の増加は、業界の成長を阻害する可能性があります。メラトニンは一般的に成人の短期使用では安全と考えられているが、長期的な安全性や他の薬物との相互作用の可能性については疑問があります。日中の眠気、頭痛、めまいなどの有害症状が観察されているが、頻度は低いです。さらに、規制状況が世界的に異なるため、基準や監視が異なり、消費者の信頼を損ないかねないです。

市場の大きな損失を避けるためには、厳密な調査、より良い表示、医療従事者の教育を通じて、これらの安全性への懸念に対処することが重要です。潜在的な危険性と効用に関する透明性は、適切なマーケティング手法とともに、消費者の信頼を維持し、健康意識の高まりと睡眠補助薬への需要の高まりの中でメラトニン産業の持続的拡大を保証するために不可欠であろう。

目次

第1章 イントロダクション

• 市場の定義
• 市場区分
• 分析手法

第2章 エグゼクティブサマリー

• 主な分析結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 メラトニン市場：原料別

• 植物
• 動物
• 細菌

第5章 メラトニン市場：種類別

• 天然メラトニン
• 合成メラトニン

第6章 メラトニン市場：エンドユーザー別

• 医薬品
• 食品・飲料
• 医療・ヘルスケア

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• 新型コロナウイルス感染症 (COVID-19) の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Melatonin Market Valuation - 2026-2032

The melatonin industry is expanding rapidly, driven by increased awareness of sleep disorders and the benefits of melatonin supplementation. Rising stress levels, a growing older population, and a shift toward natural health therapies are all contributing to market growth. North America offers a significant market share. This is likely to enable the market size surpass USD 1.86 Billion valued in 2024 to reach a valuation of around USD 4.93 Billion by 2032.

Technological advances in melatonin product formulations, as well as the growing online retail sector, are driving market expansion. The push toward tailored health and wellness solutions is also driving up demand. Natrol, Life Extension, and Swanson Health Products are key industry participants that rely on product innovation and strategic collaborations to strengthen their market positions. The rising demand for Melatonin is enabling the market grow at a CAGR of 14.30% from 2026 to 2032.

Melatonin Market: Definition/ Overview

Melatonin is a natural hormone produced by the pineal gland in the brain that regulates the sleep-wake cycle. It is commonly used as a dietary supplement to assist treat sleep disorders, jet lag and shift work-related concerns by encouraging relaxation and enhancing sleep quality.

Melatonin is generally used to regulate sleep-wake cycles, treat insomnia, and prevent jet lag. It is also used to treat sleep abnormalities in children, anxiety prior to surgery, and enhancing sleep in shift workers. Melatonin also possesses antioxidant capabilities that may aid eye health and seasonal affective disorder (SAD).

Melatonin's future applications may include mood disorders, jet lag, and immunological support, in addition to sleep regulation. Ongoing research into its antioxidant and anti-inflammatory qualities may lead to larger medicinal applications, bolstering its significance in holistic health and wellness strategies.

Will Increasing Awareness of Sleep Disorders Boost the Melatonin Market Growth?

Increasing awareness of sleep disorders is poised to significantly boost the melatonin market growth due to the substantial prevalence of these conditions among the American population.

According to the Centers for Disease Control and Prevention (CDC), around 70 million Americans suffer from chronic sleep issues, which include a variety of illnesses such as insomnia, sleep apnea and inadequate sleep length. According to the American Sleep Association, 50-70 million adults in the United States suffer from one or more sleep problems.

This increasing awareness is translating into increased consumer demand for melatonin supplements, which is driven by a better knowledge of melatonin's role in regulating sleep patterns and improving overall sleep quality. From 2007 to 2012, the National Center for Health Statistics reported a significant increase in melatonin supplement use in the United States, more than doubling from 0.6% to 1.3% of the population. This development mirrors a broader shift toward natural health therapies and individualized wellness solutions, with melatonin supplements becoming increasingly popular for their perceived effectiveness in treating sleep disturbances. As awareness grows, along with developments in melatonin product formulations and distribution channels, the market is likely to expand further to accommodate expanding customer wants and preferences.

Will Increasing Safety Issues and Adverse Effects Hamper the Melatonin Market?

Increasing safety concerns and undesirable consequences connected with melatonin use have the potential to stifle industry growth. While melatonin is generally deemed safe for short-term usage in adults, there are questions about its long-term safety and potential interactions with other drugs. Adverse symptoms such as daytime drowsiness, headaches and dizziness have been observed, but infrequently. Furthermore, the regulatory landscape differs globally, resulting in different standards and oversight, which can undermine consumer confidence.

Addressing these safety concerns through rigorous research, better labelling and healthcare provider education is critical to avoiding significant market losses. Transparency regarding potential hazards and benefits, together with appropriate marketing techniques, will be vital for maintaining consumer trust and guaranteeing the sustained expansion of the melatonin industry amidst rising health awareness and demand for sleep aids.

Category-Wise Acumens

Will Established Extraction Processes Drive the Plant Segment?

Established extraction technologies for melatonin from plants are expected to fuel expansion in the plant segment of the melatonin market. These techniques have streamlined production, resulting in constant quality and quantity of melatonin supplements. Manufacturers profit from efficient extraction processes that enhance productivity while maintaining melatonin's bioactivity, allowing them to efficiently meet consumer demands.

Furthermore, these proven techniques improve the stability and scalability of plant-derived melatonin products, increasing market competitiveness. Consumer preference for natural sources strengthens this category, as plant-based supplements coincide with expanding trends in holistic health and wellness. The regulatory clarity and safety characteristics associated with plant-derived melatonin further boost market confidence.

As awareness of melatonin's benefits continues to develop, bolstered by known extraction technologies, the plant sector is well-positioned to expand, supplying to increasing consumer interest in natural sleep aids and overall well-being.

Will Increasing Demand for High Purity and Consistency in Dosage Drive the Type Segment?

The growing need for high purity and uniformity in dosage is an important driver for the type segment of the melatonin market, particularly for synthetic melatonin. Consumers and healthcare practitioners alike value products with consistent and accurate dosing to ensure efficacy and safety in treating sleep problems and other health issues. Synthetic melatonin achieves these criteria effectively thanks to controlled manufacturing techniques that ensure purity and consistency across batches.

Furthermore, the pharmaceutical and nutraceutical businesses favor synthetic melatonin because it can meet demanding regulatory and quality control requirements. As the global market for sleep aids and dietary supplements grows, the emphasis on dependable product performance and consumer trust in dose constancy is anticipated to drive the expansion of synthetic melatonin. However, natural resources such as plant-derived melatonin also play a role, particularly among consumers seeking organic or natural options with perceived health benefits.

Country/Region-wise Acumens

Will Increasing Strong Consumer Base Consuming Dietary Supplements Drive the Market in North America?

North America's robust customer base, which values nutritional supplements, is a primary driver of the region's melatonin industry. Melatonin is becoming increasingly popular as a natural sleep aid and overall wellness supplement among North American consumers. Factors such as hurried lifestyles, rising stress levels and the incidence of sleep disorders all contribute to the need for effective remedies such as melatonin.

Furthermore, North America includes a well-developed healthcare infrastructure and regulatory framework that facilitates the distribution and sale of dietary supplements, including melatonin. Consumers in this region value health and wellness, resulting in steady growth in the market for dietary supplements such as melatonin. As a result, manufacturers and suppliers are eager to innovate and broaden their product offers to meet this growing demand, further propelling market expansion in North America.

Will Increasing Awareness of Sleep Disorders Drive the Market in Asia Pacific Region?

Growing awareness of sleep problems is projected to propel the melatonin market in Asia-Pacific (APAC). As people become more aware of the negative impacts of sleep problems like insomnia and sleep apnea, there is a greater need for effective treatments like melatonin supplements. Sleep disorders are on the rise in countries such as China, Japan and India as a result of changing lifestyles, urbanization and higher stress levels.

Furthermore, the trend towards natural health solutions is gaining traction in APAC, which is consistent with the perceived benefits of melatonin as a natural sleep aid. The region's growing middle-class population and rising disposable incomes drive demand for wellness items. As a result, there is great potential for market expansion in APAC, underpinned by higher consumption, awareness, expanding healthcare infrastructure and the introduction of innovative melatonin products tailored to regional preferences and regulatory requirements.

Competitive Landscape

The melatonin market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the melatonin market include:

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

Latest Developments

• In January 2023, Pfizer, Inc. increased its commitment to the "Agreement for a Healthier World" by offering its entire portfolio of medicines and vaccines on a not-for-profit basis to improve the health of 1.2 billion people in 45 low-income countries.
• In November 2022, Natrol introduced MelatoninMax, a sleep aid in the form of a single gummy containing 10 mg of melatonin, the maximum recommended dosage.

Melatonin Market, By Category

• Source:
• Plants
• Animals
• Bacteria
• Type:
• Natural Melatonin
• Synthetic Melatonin
• End-User:
• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Melatonin Market, By Source

• Plants
• Animals
• Bacteria

5. Melatonin Market, By Type

• Natural Melatonin
• Synthetic Melatonin

6. Melatonin Market, By End-User

• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References